Chris Chen
Chief Executive Officer, Biologics Service
Medicine
WuXi Biologics
China
Biography
Over 15 years of experience in bioprocess development, scale-up, manufacturing and quality. Formerly CEO of Shanghai Kanda; COO of Shanghai Celgen; Director of Process Science & Production at AME (now Eli Lilly), Manager of BioProcess Technology at Merck. Ph.D. from University of Delaware.
Research Interest
bioprocess development
